首页>
外国专利>
USE OF L-CARNITINES AND ACYL-L-CARNITINES FOR THE TREATMENT OF PATIENTS Suffering From AIDS-RELATED SYNDROME AND OF ASYMPTOMATIC HIV-SEROPOSITIVE PATIENTS
USE OF L-CARNITINES AND ACYL-L-CARNITINES FOR THE TREATMENT OF PATIENTS Suffering From AIDS-RELATED SYNDROME AND OF ASYMPTOMATIC HIV-SEROPOSITIVE PATIENTS
展开▼
机译:左卡尼汀和乙酰基左卡尼汀在治疗艾滋病相关症状和无症状艾滋病毒血清阳性患者中的应用
展开▼
页面导航
摘要
著录项
摘要
A novel therapeutical utilization of L-carnitine, acyl L-carnitines and the pharmacologically acceptable salts thereof is disclosed, for treating immune and metabolic alterations in patients suffering from AIDS and AIDS-related syndromes and in asymptomatic HIV-seropositive patients. The L-carnitine amount to be administered according to this novel use is about 6-8 grams daily, via the oral route or an equivalent amount of an acyl L-carnitine or a pharmacologically acceptable salt thereof, i.e. three-four times as much the dose usually administered for the already known therapeutic uses of L-carnitine.
展开▼